https://www.zacks.com/stock/news/2243668/compelling-reasons-to-hold-on-to-allstate-all-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2243668
Mar 20, 2024 - Allstate (ALL) remains well-poised for growth on the back of continued rate hikes, strong investment results, divestitures and adequate cash reserves.
zc:-5154637001852617114
0
https://www.zacks.com/stock/news/2243599/all-you-need-to-know-about-arch-capital-acgl-rating-upgrade-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2243599
Mar 20, 2024 - Arch Capital (ACGL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zc:4420042232539160759
0
https://www.wired.com/story/measles-us-cases-vaccinations-2024/
Mar 20, 2024 - The CDC is begging Americans to get vaccinated against measles as cases continue to rise.
0
wr:-1434219200729442726
0
https://www.fool.com/investing/2024/03/21/chipotle-stock-still-has-big-upside-according-to-1/?source=iedfolrf0000001
Mar 21, 2024 - A price target of $3,300 might seem ambitious, but the data suggests it's well within reach.
0
fool:-3256552151039733253
0
https://seekingalpha.com/article/4679653-nissan-its-all-about-electrification-and-china-rating-upgrade?source=feed_tag_japan
Mar 21, 2024 - Nissan Motor's electrification plans and success in the China market are expected to drive its share price higher. Click here to read an analysis of NSANY stock.
0
sa:3492863011170531009
0
https://www.zacks.com/stock/news/2244288/all-you-need-to-know-about-oncobiologics-otlk-rating-upgrade-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2244288
Mar 21, 2024 - Oncobiologics (OTLK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
zc:6688554435960035148
0
https://www.zacks.com/stock/news/2244290/all-you-need-to-know-about-gatx-gatx-rating-upgrade-to-strong-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2244290
Mar 21, 2024 - GATX (GATX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
zc:-2914675742522438741
0
https://www.zacks.com/stock/news/2244287/all-you-need-to-know-about-edgewell-personal-epc-rating-upgrade-to-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2244287
Mar 21, 2024 - Edgewell Personal (EPC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zc:-7702829849011978546
0
https://www.zacks.com/stock/news/2244284/all-you-need-to-know-about-netflix-nflx-rating-upgrade-to-strong-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2244284
Mar 21, 2024 - Netflix (NFLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
zc:-4183135791568870351
0
https://www.fool.com/investing/2024/03/22/with-shares-near-all-time-highs-is-it-a-buy/?source=iedfolrf0000001
Mar 22, 2024 - The success of Ozempic and Wegovy has fueled Novo Nordisk stock to new highs.
0
fool:4246263758366513347
0